Latest news
AstraZeneca shares slump after $400bn BMS merger rumours - Pharmaceutical TechnologyPharmaceutical Technology · Tue, 04 Aug 2026 08:57:27 GMTKioxia Earnings Preview: Can Stock Rebound After 60% Slump? NAND Supply and Buybacks Are Key - TradingKeyTradingKey · Thu, 30 Jul 2026 07:00:00 GMTDeFi Technologies CEO Addresses Share Slump, Details Strategy Amid Crypto Downturn - The Globe and MailThe Globe and Mail · Tue, 28 Jul 2026 12:50:00 GMT